Benign prostatic hyperplasia: a global challenge of the ageing population

Demographic changes related to a consistent improvement in life expectancy are undeniably increasing the proportion of ageing populations across the world. Consequently, with this demographic transition comes the challenge of diagnosing and treating comorbidities associated with older age. In The Lancet Healthy Longevity, the GBD 2019 Benign Prostatic Hyperplasia Collaborators investigate the global burden of benign prostatic hyperplasia and its implications in terms of disability-adjusted life-years (DALYs).